Miguel Angel Materin

Miguel A. Materin, MD serves as Division Chief of Ocular Oncology, Professor of Ophthalmology, Professor of Radiation Oncology at Duke Eye Center. 

His full-time clinical practice involves diagnosis and treatment of patients with ocular tumors. He specializes in ocular melanoma, retinoblastoma, choroidal hemangioma, retinal hemangioblastoma, ocular metastases, astrocytic retinal tumors and tumors related to other conditions or syndromes, such as von Hippel Lindau disease, Tuberous Sclerosis among others. 

Dr. Materin joined Duke in September 2016 from Yale University School of Medicine where he was an Associate Professor of Ophthalmology & Visual Science, and Director of Ophthalmic Oncology at Smilow Cancer Hospital at Yale New Haven.

Prior to his appointment at Yale, he was the Director of Diagnostic Studies and Research Fellows for the Ocular Oncology Service at Wills Eye Hospital at Thomas Jefferson University in Philadelphia, where he completed his fellowship in ocular oncology in 1999.

He is an internationally recognized ocular oncologist who has more than 100 publications in peer-reviewed literature, including journals and book chapters. Dr. Materin has been invited as a visiting professor in the U.S., Canada, Israel, Spain, Brazil, Puerto Rico, Argentina, and has given more than 300 lectures.

Dr. Materin received the Achievement Award and Senior Achievement Award from the American Academy of Ophthalmology. He is a Member of Merit of Clinica Barraquer (Barcelona, Spain) and Colombian Society of Ophthalmology. He is an active member of the International Society of Ocular Oncology, American Academy of Ophthalmology, Pan American Association of Ophthalmology.

Dr. Materin served on the education committee of the American Association of Ocular Oncology and Pathology and is past-President of the Pan American Society of Ocular Oncology. He is a Panel Member of the National Comprehensive Cancer Network for Uveal Melanoma.